The ‘professional, experienced, talented and dedicated’ team at Arnon, Tadmor-Levy maintains its stellar reputation for handling the full gamut of issues across the sector, including matters concerning the secondary use of health data collaborations, material transfer arrangements, and manufacturing agreements. In Jerusalem, Barry Levenfeld regularly acts for both domestic and international life sciences companies in M&A, private equity, and licensing transactions; the ’tremendous’ Daniel Green’s primary areas of focus are technology and licensing transactions within the medical device, pharma, and IT industries; and the ‘amazing’ Yoheved Novogroder Shoshan is well-versed in IP law, assisting global pharma entities and investors on in-licensing and R&D collaborations. Working out of the Tel Aviv office, Efrat Shapira-Orren is known for her exceptional experience in assisting private hospitals and medical centers on an array of regulatory issues. Miriam Friedmann is noted for deep expertise in licensing and privacy issues.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

‘Excellent and responsive lawyers with deep experience in life sciences. High ethical standards, first-class analysis and practical advice.’
‘Daniel Green is a tremendous life sciences lawyer, who gives strong practical advice.’
‘Avital Bruker Yamini is very professional, fast and pleasant. Also, I find that her thinking is always deep and outside the box, and consulting her gives me a very high added value.’
‘The team's strength lies with their ability to provide a strong and consistent performance in difficult situations and challenges that lie in our path. The team is thorough, highly trained and qualified in their analysis and assessment of complex issues and concerns that arise. It’s a great privilege to work with such a professional, experienced, talented and dedicated group.’
‘A high-quality, professional and leading office, with excellent legal capabilities and service. Efrat Shapira is an excellent leader.’
‘Efrat Shapira has a lot of experience, with professionalism and knowledge of the complicated and challenging system, with the provision of personal service in complex and sensitive issues.’
‘Understanding the legal aspects of healthcare and life sciences is crucial. It requires not just knowledge of corporate law but also a comprehensive understanding of the therapeutic areas and how innovative technologies impact the legal aspects of this sector. Arnon, Tadmor-Levy team holds this broad experience, quickly identifies the client's need, and provides professional, prompt, and thorough responses. They also communicate effectively throughout the process.’
‘Yoheved Novogroder Shoshan is an amazing partner. She and her team members are experts at representing me and protecting my interests in the long term. Their legal team is also creative and able to find solutions that work for both sides in a timely manner. The individuals I have worked with have always been communicative, thorough, and quick to respond, which is crucial for our business.’

Key clients

Assuta Medical Centers Ltd. and all subsidiaries
Assuta Ashdod Ltd.
ImmPact Bio
Patho-Lab Diagnostics Ltd.
Incentive Incubator Ltd.
SAREL Supplies & Services for Medicine Ltd.
Priothera
Skip Therapeutics Ltd.,
Sinusafe Medical Ltd.
Allergan Plc
Stryker Corporation
Super Spectra
Alpha Bio Tec. Ltd.
Endomatic Ltd.
Medison Pharma Group
Heracure Medical
Bio Refine Ltd.
Bioventus LLC
Barclays Capital
Pocared Diagnostics Ltd.
Boston Scientific
Oculis Holding AG (NASDAQ OCS)
FutuRx – The Biotech Accelerator
MEDX XELERATOR
ALYN Hospital
Sirvir Ltd.
Prilenia Therapeutics
Hubei Forbon Technology Co., Ltd.
Alma Lasers Ltd.
Integra Holdings
Simplificare, Inc.
Oramed Pharmaceuticals
Premia Spine
RMDY Health
On-Sight Medical
Genmab A/S
Bio-Change
BioLineRx Ltd.
Hedonia Ltd.
Amylyx Pharmaceuticals
Immunogen
BSense
Append Medical
BeWeld Medical
Veinway
CatchMe Therapeutics
Swift Duct

Work highlights

Represented Assuta Medical Centers Ltd. on all legal and regulatory aspects of two incidents of alleged genetic mismatch between a child, who has been conceived through IVF, and one or both of the child's parents.
Assisted the incubator FuturRX (an incubator formed by Orbimed, J&J and Takeda) and its portfolio companies (including ImmPACT Ltd., ImmPACT Inc., MOYA Bio Ltd., RaminoBio Ltd. BSense, and Skip Therapeutics Ltd.) in IP transactions, including representing Skip Therapeutics Ltd. in a collaboration and right to license agreement with Sheba Medical Center relating to Skip’s computational and prioritization platform for splicing manipulation therapies in rare genetic disorders, a collaboration which, due the cutting-edge nature of the technology necessitated an innovative approach.
Assisted the MedTech incubator MedXXelerator in multiple funding rounds.